Ingredient in common cough medicine may aid diabetes treatment
the ONA take:
An ingredient found in common cough medicine may be able to aid in the treatment of patients with type 2 diabetes, according to a study published in Nature Medicine.
Researchers examined the effects of dextromethorphan, an active ingredient in cough suppressants, in order to build on prior research which showed that it had potential impact on receptor cells in the pancreas. Initially they hypothesized that the compound would actually worsen insulin production.
Instead, the team found that the ingredient caused the receptor cells to boost insulin production in the pancreas.
They tested the effect with a single-dose trial in 20 male patients with diabetes and found that the men “showed enhanced serum insulin concentrations and glucose tolerance.”
Findings, however, are still preliminary, and the researchers advise against diabetics self-medicating with cough medicine. Future testing was encouraged by the team.
An ingredient found in common cough medicine may be able to aid in the treatment of patients with type 2 diabetes.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|